Ojima T. · Hayata K. · Kitadani J. · Takeuchi A. · Yamaue H.

Log in to MyKarger to check if you already have access to this content.

Buy FullText & PDF Unlimited re-access via MyKarger Unrestricted printing, no saving restrictions for personal use read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!

If you would like to redeem your KAB credit, please log in.

Save over 20% compared to the individual article price.

Learn more

Access via DeepDyve Unlimited fulltext viewing Of this article Organize, annotate And mark up articles Printing And downloading restrictions apply

Select

Subscribe Access to all articles of the subscribed year(s) guaranteed for 5 years Unlimited re-access via Subscriber Login or MyKarger Unrestricted printing, no saving restrictions for personal use read more

Subcription rates

Select

* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

Received: June 29, 2022
Accepted: August 25, 2022
Published online: October 21, 2022

Number of Print Pages: 8
Number of Figures: 0
Number of Tables: 4

ISSN: 0030-2414 (Print)
eISSN: 1423-0232 (Online)

For additional information: https://www.karger.com/OCL

Abstract

Introduction: Robotic surgery is regarded as an evolved type of laparoscopic surgery. Few studies have undertaken detailed analysis of complications following robotic gastrectomy for gastric cancer. Methods: This is a single-center retrospective study of 149 consecutive patients with gastric cancer who underwent robotic gastrectomy. It examines in detail the postoperative complications in robotic gastrectomy for gastric cancer, focusing on intra-abdominal infectious complications including anastomotic leakage, pancreatic fistula and intra-abdominal abscess. We also aim to identify the related risk factors. Results: The median operation time was 299 min and median bleeding was 25 ml. The incidence of overall complications higher than grade II was 8.7%. Clinically serious complications higher than grade IIIa occurred in 6.7% of cases. The incidence of intra-abdominal infectious complications that were higher than grade II was 4.0%. Mortality in our consecutive series was zero. Multivariate logistic regression analysis indicated that postoperative intra-abdominal infectious complications were significantly associated with history of abdominal surgery (P = 0.043), with odds ratios of 17.890 (95 % confidence interval 1.092 – 293.150) and with non-curative resection (P = 0.025), with odds ratios of 58.629 (95 % confidence interval 1.687 – 2037.450). Discussion/Conclusion: Robotic gastrectomy was shown to be a safe and effective treatment for gastric cancer when performed by experienced surgeons. Attention should be paid to the risk of developing postoperative complications when performing robotic gastrectomy in gastric cancer patients with a history of abdominal surgery and in patients with advanced gastric cancer in whom there is expected to be difficulty in curative resection.

S. Karger AG, Basel

References Lu J, Zheng CH, Xu BB, Xie JW, Wang JB, Lin JX, et al. Assessment of robotic versus laparoscopic distal gastrectomy for gastric cancer: a randomized controlled trial. Ann Surg. 2021;273(5):858–67. Eom BW, Yoon HM, Ryu KW, Lee JH, Cho SJ, Lee JY, et al. Comparison of surgical performance and short-term clinical outcomes between laparoscopic and robotic surgery in distal gastric cancer. Eur J Surg Oncol. 2012;38(1):57–63. Hu LD, Li XF, Wang XY, Guo TK. Robotic versus laparoscopic gastrectomy for gastric carcinoma: a meta-analysis of efficacy and safety. Asian Pac J Cancer Prev. 2016;17(9):4327–33. Baek SJ, Lee DW, Park SS, Kim SH. Current status of robot-assisted gastric surgery. World J Gastrointest Oncol. 2011;3(10):137–43. Yang SY, Roh KH, Kim YN, Cho M, Lim SH, Son T, et al. Surgical outcomes after open, laparoscopic, and robotic gastrectomy for gastric cancer. Ann Surg Oncol. 2017;24:1770–7. Wang WJ, Li R, Guo CA, Li HT, Yu JP, Wang J, et al. Systematic assessment of complications after robotic-assisted total versus distal gastrectomy for advanced gastric cancer: a retrospective propensity score-matched study using Clavien-Dindo classification. Int J Surg. 2019;71:140–8. Ye SP, Shi J, Liu DN, Jiang QG, Lei X, Qiu H, et al. Robotic-assisted versus conventional laparoscopic-assisted total gastrectomy with D2 lymphadenectomy for advanced gastric cancer: short-term outcomes at a mono-institution. BMC Surg. 2019;19(1):86. Li ZY, Zhao YL, Qian F, Tang B, Chen J, Zhang F, et al. Incidence and risk factors of postoperative complications after robotic gastrectomy for gastric cancer: an analysis of 817 cases based on 10-year experience in a large-scale center. Surg Endosc. 2021;35(12):7034–41. Ojima T, Nakamura M, Hayata K, Kitadani J, Katsuda M, Takeuchi A, et al. Short-term outcomes of robotic gastrectomy vs laparoscopic gastrectomy for patients with gastric cancer: a randomized clinical trial. JAMA Surg. 2021;156(10):954–63. Brierley JD, Gospodarowicz MK, Wittekind C, editors. TNM classification of malignant tumours. 8th ed. New York: Wiley-Blackwell; 2017 Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205–13. Ojima T, Nakamura M, Nakamori M, Hayata K, Katsuda M, Maruoka S, et al. Robotic radical lymphadenectomy without touching the pancreas during gastrectomy for gastric cancer. Medicine. 2019;98(13):e15091. Ojima T, Nakamura M, Hayata K, Kitadani J, Takeuchi A, Yamaue H. Robotic subtotal gastrectomy with small remnant stomach for gastric cancer in the upper stomach. J Gastrointest Surg. 2021;25(8):2165–71. Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2018 (5th edition). Gastric Cancer. 2021;24:1–21. Ojima T, Nakamura M, Hayata K, Yamaue H. Laparoscopic Roux-en-Y reconstruction using conventional linear stapler in robotic total gastrectomy for gastric cancer. Surg Oncol. 2020;33:9–10. Ojima T, Nakamura M, Yamaue H. Full robotic Roux-en-Y reconstruction after gastrectomy for gastric cancer: a loop reconstruction technique. Updates Surg. 2020;72(4), 1279–81. Ojima T, Nakamura M, Hayata K, Yamaue H. Robotic double tract reconstruction after proximal gastrectomy for gastric cancer. Ann Surg Oncol. 2021;28(3):1445–6. Ojima T, Nakamori M, Nakamura M, Hayata K, Maruoka S, Yamaue H. Fundoplication with 180-degree wrap during esophagogastrostomy after robotic proximal gastrectomy for early gastric cancer. J Gastrointest Surg. 2018;22(8):1475–6. Li ZY, Zhou YB, Li TY, Li JP, Zhou ZW, She JJ, et al. Robotic gastrectomy versus laparoscopic gastrectomy for gastric cancer: a multicenter cohort study of 5402 patients in China. Ann Surg. 2021 Jul 2. Epub ahead of print. Shimoike N, Nishigori T, Yamashita Y, Kondo M, Manaka D, Kadokawa Y, et al. Safety assessment of robotic gastrectomy and analysis of surgical learning process: a multicenter cohort study. Gastric Cancer. 2022;25(4), 817–26. Shibasaki S, Nakauchi M, Serizawa A, Nakamura K, Akimoto S, Tanaka T, et al. Clinical advantage of standardized robotic total gastrectomy for gastric cancer: a single-center retrospective cohort study using propensity-score matching analysis. Gastric Cancer. 2022;25(4):804–16. Omori T, Yamamoto K, Hara H, Shinno N, Yamamoto M, Fujita K, et al. Comparison of robotic gastrectomy and laparoscopic gastrectomy for gastric cancer: a propensity score-matched analysis. Surg Endosc. 2022;36(8):6223–34. Choi S, Song JH, Lee S, Cho M, Kim YM, Kim HI, et al. Trends in clinical outcomes and long-term survival after robotic gastrectomy for gastric cancer: a single high-volume center experience of consecutive 2000 patients. Gastric Cancer. 2022;25(1):275–86. Yoshida K, Honda M, Kumamaru H, Kodera Y, Kakeji Y, Hiki N, et al. Surgical outcomes of laparoscopic distal gastrectomy compared to open distal gastrectomy: a retrospective cohort study based on a nationwide registry database in Japan. Ann Gastroenterol Surg. 2018;2(1):55–64. Liao G, Wen S, Xie X, Wu Q. Laparoscopic gastrectomy for remnant gastric cancer: risk factors associated with conversion and a systematic analysis of literature. Int J Surg. 2016;34:17–22. Yamashita K, Miyazaki Y, Takahashi T, Masuike Y, Motoori M, Kimura Y, et al. Safety and feasibility of laparoscopic gastrectomy for gastric cancer patients with a history of abdominal surgery. Surg Today. 2017;47(10):1274–81. Nagai E, Nakata K, Ohuchida K, Miyasaka Y, Shimizu S, Tanaka M. Laparoscopic total gastrectomy for remnant gastric cancer: feasibility study. Surg Endosc. 2014;28(1):289–96. Tsunoda S, Okabe H, Obama K, Tanaka E, Akagami M, Kinjo Y, et al. Laparoscopic gastrectomy for patients with a history of upper abdominal surgery: results of a matched-pair analysis. Surg Today. 2014;44(2):271–6. Kwon IG, Cho I, Guner A, Choi YY, Shin HB, Kim HI, et al. Minimally invasive surgery for remnant gastric cancer: a comparison with open surgery. Surg Endosc. 2014;28:2452–8. Biondi A, D’Ugo D, Cananzi F, Rausei S, Sicoli F, Santullo F, et al. Prognostic indicators in stage IV surgically treated gastric cancer patients: a retrospective multi-institutional study. Dig Surg. 2019;36(4):331–9. Mahar AL, Coburn NG, Singh S, Law C, Helyer LK. A systematic review of surgery for non-curative gastric cancer. Gastric Cancer. 2012;15 Suppl 1:S125–37. Sun J, Song Y, Wang Z, Chen X, Gao P, Xu Y, et al. Clinical significance of palliative gastrectomy on the survival of patients with incurable advanced gastric cancer: a systematic review and meta-analysis. BMC Cancer. 2013;13:577. Article / Publication Details

Received: June 29, 2022
Accepted: August 25, 2022
Published online: October 21, 2022

Number of Print Pages: 8
Number of Figures: 0
Number of Tables: 4

ISSN: 0030-2414 (Print)
eISSN: 1423-0232 (Online)

For additional information: https://www.karger.com/OCL

Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.